Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio

By Mercier-Letondal P.   Montcuquet N.   Sauce D.   Certoux J-M   Jeanningros S.   Ferrand C.   Bonyhadi M.   Tiberghien P.   Robinet E.  

Cytotherapy, Vol. 10, Iss. 3, 2008-03 ,pp. : 275-288

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of natural killer cells for clinical applications

By Klingemann H-g   Martinson J  

Cytotherapy, Vol. 6, Iss. 1, 2004-01 ,pp. : 15-22

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of natural killer cells: a question of function

By Sutlu Tolga   Alici Evren  

Cytotherapy, Vol. 13, Iss. 6, 2011-07 ,pp. : 767-768

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

By Lapteva Natalia   Durett April G.   Sun Jiali   Rollins Lisa A.   Huye Leslie L.   Fang Jian   Dandekar Varada   Mei Zhuyong   Jackson Kimberley   Vera Juan   Ando Jun   Ngo Minhtran C.   Coustan-Smith Elaine   Campana Dario   Szmania Susann   Garg Tarun   Moreno-Bost Amberly   Vanrhee Frits   Gee Adrian P.   Rooney Cliona M.  

Cytotherapy, Vol. 14, Iss. 9, 2012-10 ,pp. : 1131-1143

Ashgate Publishing Ltd

Access to resources Recommend Favorite